Zalix Pharmaceuticals Private Limited
About Zalix Pharmaceuticals Private Limited
Data last updated:
Zalix Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74993DL2018PTC333678.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shivali Choudhary and Ubraj Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 34/4 Basement Office No. 3 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.
Company details
Contact details
Zalix Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 34/4 Basement Office No. 3 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zalix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zalix Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zalix Pharmaceuticals Private Limited, buy the company report.
Financials of Zalix Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Zalix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zalix Pharmaceuticals Private Limited
Zalix Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivali Choudhary Also directs: Zymes Bioscience Private Limited | Director | 09 May 2018 | 8 Years 6 Months | Current |
| Ubraj Singh Also directs: Ubix Bioscience Private Limited | Director | 27 Jul 2018 | 8 Years 3 Months | Current |
| Binny Chopra Also directs: Awake Life Sciences LLP | Director | 24 May 2021 | 5 Years 5 Months | Current |
Auditor
Zalix Pharmaceuticals Private Limited is audited by SAURABH AGRAWAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAURABH AGRAWAL & CO | FY 2021 | 019761C |
Shareholding
The shareholding of Zalix Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zalix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zalix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zalix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zalix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zalix Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Binny Chopra was appointed as Director on 24 May 2021.
Frequently asked questions
Zalix Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 May 2018 (8+ years old) and is registered under CIN U74993DL2018PTC333678.
Zalix Pharmaceuticals has 3 current directors:
- Shivali Choudhary - Director
- Ubraj Singh - Director
- Binny Chopra - Director
The latest financial statements of Zalix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Zalix Pharmaceuticals is U74993DL2018PTC333678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zalix Pharmaceuticals was incorporated on 09 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Binny Chopra was appointed as Director on 24 May 2021. Ubraj Singh ceased to be Director on 22 May 2021. Manju Garg ceased to be Director on 27 Jul 2018. Zalix Pharmaceuticals has 5 board changes on record in total.
The registered office of Zalix Pharmaceuticals is at F – 344 Basement Office No. 3 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.
Zalix Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Zalix Pharmaceuticals can be reached at its registered office: F – 344 Basement Office No. 3 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.
Zalix Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
